Johnson & Johnson CDR (JNJ0)
XDUS
21.20
+0.20 (+0.95%)
Closed
Aug 24, 2026
Day's Range
20.6021.20
52 wk Range
13.5021.60
Financial Statements - JNJ0 - Johnson & Johnson CDR
Revenue
94.19B▲ 23.4%
Net Income
26.80B▲ 121.7%Net Margin 28.5%
EBITDA
35.16B▲ 28.1%
Free Cash Flow
19.31B▲ 24.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 94.19B | 76.35B | 85.15B | 79.99B | 78.74B | 82.58B |
| Cost of Goods | 30.25B | 23.61B | 26.55B | 24.59B | 23.40B | 28.42B |
| Gross Profit | 63.93B | 52.74B | 58.60B | 55.39B | 55.33B | 54.15B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 25.59B | 19.04B | 23.40B | 21.01B | 20.94B | 19.73B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 6.89B | -5.19B | -8.80B | -1.86B | -1.63B | -3.14B |
| Pre Tax Income | 32.58B | 14.34B | 15.06B | 19.35B | 19.17B | 16.49B |
| Income Tax | 5.77B | 2.25B | 1.73B | 2.98B | 1.37B | 1.78B |
| Net Income | 26.80B | 12.09B | 35.15B | 17.94B | 20.87B | 14.71B |
| EPS Basic | 1.082171 | 0.568133 | 1.34937 | 0.663991 | 0.770986 | 0.543372 |
| EPS Diluted | 1.072302 | 0.562886 | 1.333816 | 0.65427 | 0.759264 | 0.535665 |
| Basic Shares Outstanding | 24.76B | 21.28B | 27.12B | 28.10B | 28.14B | 28.18B |
| Diluted Shares Outstanding | 24.76B | 21.28B | 27.12B | 28.10B | 28.14B | 28.18B |
| Ebit | 33.55B | 14.99B | 15.83B | 19.63B | 19.36B | 16.69B |
| Ebitda | 35.16B | 27.44B | 32.32B | 27.66B | 27.86B | 24.17B |
| Net Income Continuous Operations | 26.80B | 12.09B | 35.15B | 17.94B | 20.87B | 14.71B |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
